Trial intelligence / Profile preview

Dose-finding study of Bromelain in acute sinusitis

2005-005654-53Phase 2Completed

Sponsor
URSAPHARM
Start
Oct 2006
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of bromelain in acute rhinosinusitis (ARS), sponsored by URSAPHARM. Started Oct 2006; status: completed.

02

Drugs

bromelain
03

Conditions

acute rhinosinusitis (ARS)

Beyond the preview

Go deeper on 2005-005654-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005654-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call